Zoetis Inc. Profile Avatar - Palmy Investing

Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattl…
Drug Manufacturers - Specialty & Generic
US, Parsippany [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 33% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -23.21 87.69 114.20
Graham Fair Price 7.70 18.03 16.74
PEG -42.29 2.14 -3.71
Price/Book -16.58 15.12 18.13
Price/Cash Flow 29.72 168.12 129.60
Prices/Earnings -25.99 31.93 43.14
Price/Sales -14.67 34.93 40.94
Price/FCF 29.72 168.12 129.60
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 5.38 0.69 0.65
Operating Margin 14.16 0.37 0.32
ROA 13.60 0.04 0.04
ROE 0.11 0.12 12.72
ROIC 0.05 0.06 12.28
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ < 0.005 < 0.005 -43.59
Dividends QOQ < 0.005 0.15 5083.93
EBIT QOQ -0.15 0.13 -14.58
EPS QOQ -0.12 0.15 28.25
FCF QOQ 0.21 -0.35 68.43
Revenue QOQ 0.03 -0.01 -63.94
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 301.65 350.87 16.32
Days Sales Outstanding (DSO) 53.03 53.14 0.20
Inventory Turnover 0.30 0.26 -14.03
Debt/Capitalization 0.57 0.57 -0.71
Quick Ratio 1.77 1.71 -3.33
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 10.89 11.04 1.44
Cash 4.45 4.31 -3.02
Capex -0.43 -0.31 29.14
Free Cash Flow 1.52 0.99 -34.76
Revenue 4.82 4.78 -0.82
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 3.36 3.33 -0.80
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 5.70 5.17 -9.30
Naive Interpretation Member
06 - Financial Health · Bad